Guj. Kidney & Super
Ticker > Company >

Guj. Kidney & Super share price

Gujarat Kidney And Super Speciality Ltd.

NSE: GKSL BSE: 544666 SECTOR: Hospital & Healthcare Services  1.83 K   0   0

110.60
+0.20 (0.18%)
BSE: 13 Feb 04:01 PM

Price Summary

Today's High

₹ 113.4

Today's Low

₹ 109.95

52 Week High

₹ 115.4

52 Week Low

₹ 98.25

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 872.01 Cr.

Enterprise Value

₹ 872.78 Cr.

No. of Shares

7.88 Cr.

P/E

599.78

P/B

0

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  0

CASH

₹ 1.18 Cr.

DEBT

₹ 1.94 Cr.

Promoter Holding

71.45 %

EPS (TTM)

₹  0.18

Sales Growth

0%

ROE

131.97 %

ROCE

30.01%

Profit Growth

0 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year∞%
3 YearNA
5 YearNA

Profit Growth

1 Year23545.16%
3 YearNA
5 YearNA

ROE%

1 Year131.97%
3 Year52.19%

ROCE %

1 Year30.01%
3 Year22.24%

Debt/Equity

1.0632

Price to Cash Flow

-413.19

Interest Cover Ratio

49.9295

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2025 71.45 0.00
Sep 2025 71.45 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 52.1927333333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 22.2428333333333% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 49.9295.
  • The company has an efficient Cash Conversion Cycle of -3273.1738 days.
  • The company has a high promoter holding of 71.45%.
  • Promoter stake has increased from 0% to 71.45% in the last 1 quarter.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • Company has high debtor days of 194.5098.
  • Company has negative cash flow from operations of -2.1104.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 384.686.

Quarterly Result (All Figures in Cr.)
 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024
Net Sales 0.79 0 4.98
Total Expenditure 0.07 0.01 3.42
Operating Profit 0.72 -0.01 1.56
Other Income 0 0 0.7
Interest 0.01 0 0.04
Depreciation 0.57 0 0.28
Exceptional Items 0 0 0
Profit Before Tax 0.13 -0.01 1.94
Tax 0.04 0 0.49
Net Profit 0.1 -0.01 1.45
Adjusted EPS (Rs.) 0.03 0 0.42

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 0.2 0.2 0.2
Total Reserves 0.18 0.17 10.69
Borrowings 0 0 1.53
Other N/C liabilities -0.04 -0.04 0.16
Current liabilities 3.55 3.5 4.14
Total Liabilities 3.89 3.83 16.73
Assets
Net Block 2.67 2.67 9.74
Capital WIP 0 0 0
Intangible WIP 0 0 0
Investments 0 0.01 0
Loans & Advances 0 0 0.18
Other N/C Assets 0.01 0 0
Current Assets 1.21 1.15 6.81
Total Assets 3.89 3.83 16.73
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.13 -0.01 1.94
Adjustment 0.57 0 0.32
Changes in Assets & Liabilities -0.67 0.01 -3.84
Tax Paid -0.04 0 -0.54
Operating Cash Flow 0 0 -2.11
Investing Cash Flow 0 0 -7.35
Financing Cash Flow 0 0 10.63
Net Cash Flow 0 0 1.17

Corporate Actions

Investors Details

PARTICULARS Sep 2025% Dec 2025%
promoters 71.45 71.45
anitaben yashwantsinh bha... - 11.10
bhartiben pragnesh bharpo... 11.10 11.10
pragnesh yashwantsinh bha... 38.16 38.16
yashwantsingh motisingh b... 11.10 11.10
anitaben nayak 11.10 -
PARTICULARS Sep 2025% Dec 2025%
investors 28.55 28.55
astorne capital vcc - arv... 2.15 1.83
craft emerging market fun... - 1.11
craft emerging market fun... 3.89 3.89
khandelwal finance privat... 1.67 1.67
llp 0.01 0.85
venus investments vcc - v... - 1.11
craft emerging market fun... 1.11 -
minerva ventures fund 1.07 -
rajasthan global securiti... 1.07 -
shine star build cap pvt ... 2.15 -
venus investments vcc - v... 1.11 -

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Guj. Kidney & Super Stock Price Analysis and Quick Research Report. Is Guj. Kidney & Super an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Guj. Kidney & Super. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Guj. Kidney & Super has a PE ratio of 599.023861171366 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Guj. Kidney & Super has ROA of 14.14% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Guj. Kidney & Super has a Current ratio of 1.6433.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Guj. Kidney & Super has a ROE of 131.9655%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Guj. Kidney & Super has a Debt to Equity ratio of 1.0632 which means that the company has low proportion of debt in its capital.

  • Sales growth: Guj. Kidney & Super has reported revenue growth of 0% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Guj. Kidney & Super for the current financial year is 31.3512862220616%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Guj. Kidney & Super is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Guj. Kidney & Super is Rs 0.1844. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Guj. Kidney & Super in Ticker for free. Also, one can get the intrinsic value of Guj. Kidney & Super by using Valuation Calculators, which are available with a Finology ONE subscription. 

Guj. Kidney & Super FAQs

Q1. What is Guj. Kidney & Super share price today?
Ans: The current share price of Guj. Kidney & Super is Rs 110.46.

Q2. What is the market capitalisation of Guj. Kidney & Super?
Ans: Guj. Kidney & Super has a market capitalisation of Rs 870.9025395 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Guj. Kidney & Super?
Ans: The PE ratio of Guj. Kidney & Super is 599.023861171366 and the P/B ratio of Guj. Kidney & Super is 0, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Guj. Kidney & Super share?
Ans: The 52-week high share price of Guj. Kidney & Super is Rs 123, and the 52-week low share price of Guj. Kidney & Super is Rs 98.36.

Q5. Does Guj. Kidney & Super pay dividends?
Ans: Currently, Guj. Kidney & Super does not pay dividends. Dividend yield of Guj. Kidney & Super is around 0%.

Q6. What are the face value and book value of Guj. Kidney & Super shares?
Ans: The face value of Guj. Kidney & Super shares is Rs 2, while the book value per share of Guj. Kidney & Super is around Rs 0. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Guj. Kidney & Super?
Ans: Guj. Kidney & Super has a total debt of Rs 1.9439 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Guj. Kidney & Super?
Ans: The ROE of Guj. Kidney & Super is 131.9655% and ROCE of Guj. Kidney & Super is 30.0092%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Guj. Kidney & Super a good buy for the long term?
Ans: The Guj. Kidney & Super long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Guj. Kidney & Super undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Guj. Kidney & Super appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Guj. Kidney & Super’s financials?
Ans: You can review Guj. Kidney & Super’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Guj. Kidney & Super

Gujarat Kidney Share Price, Stock Analysis & Company Profile

Welcome to the comprehensive stock analysis page for Gujarat Kidney and Super Speciality Ltd. Here, you can track the live Gujarat Kidney share price, analyse the company's financial health, and stay updated with the latest market news. Whether you are tracking the Gujarat Kidney share price today for a potential investment or monitoring your portfolio, this page provides all the essential tools and reports for a detailed stock analysis.

About Gujarat Kidney and Super Speciality Ltd.

Gujarat Kidney and Super Speciality Ltd. (GKSL) is a prominent multi-speciality healthcare provider based in Gujarat, India. Established in 2019, the company has grown into a significant regional player by delivering high-quality secondary and tertiary healthcare services.

While the company has a strong foundation in renal sciences—specialising in nephrology, urology, and renal transplantation—it has successfully diversified its expertise. Today, GKSL operates a network of seven multi-speciality hospitals and four pharmacies across cities like Vadodara, Bharuch, Godhra, Borsad, and Anand. Its facilities offer a wide range of treatments, including general medicine, laparoscopic surgery, orthopaedics, trauma care, and non-interventional cardiology.

Gujarat Kidney Business Model

Gujarat Kidney and Super Speciality operates on a unique and efficient business model designed for scalability and profitability:

  1. Asset-Light Operations: Unlike traditional hospital chains that invest heavily in land and buildings, GKSL expands primarily through leasing facilities or acquiring controlling stakes in existing hospitals. This "asset-light" approach reduces capital expenditure and allows for faster expansion.

  2. Integrated Healthcare Services: The company generates revenue through multiple channels, including Inpatient Department (IPD) services, Outpatient Department (OPD) consultations, and the sale of pharmaceutical products through its hospital-attached pharmacies.

  3. Hub-and-Spoke Strategy: By focusing on strategic locations in central Gujarat, the company maximises operational efficiency, sharing resources and medical expertise across its network of hospitals.

Gujarat Kidney IPO and Listing Details

Gujarat Kidney and Super Speciality Ltd. made its debut on the Indian stock market in December 2025. Below are the static details regarding its initial public offering (IPO) and listing, which serve as a permanent reference for investors analysing the stock's history.

  • Listing Date: 30 December 2025

  • IPO Price Band: Rs 108 to Rs 114 per share

  • Face Value: Rs 2 per share

  • Lot Size: 128 Shares

  • Listing Exchanges: BSE and NSE

  • Registrar: MUFG Intime India Pvt. Ltd.

Investor Resources Available on This Page

We believe in empowering retail investors with professional-grade data. On this page, you can access a wealth of information to conduct your own Gujarat Kidney stock analysis:

  • Price Chart: View price movements and historical performance trends to identify entry and exit points.

  • Company Ratios: Analyse key financial metrics such as the PE ratio, ROE, and ROCE to determine if the stock is undervalued or overvalued.

  • Quarterly Results & Balance Sheet: Scrutinise the company’s quarterly earnings, profit and loss accounts, and balance sheets to assess its financial stability.

  • Cash Flow Statements: Check the cash flow analysis to understand how the company manages its liquidity and operational cash.

  • Shareholding Pattern: Review the ownership structure, including holdings by promoters, FIIs, and DIIs, to gauge market confidence.

  • Pros & Cons: Read a simplified summary of the company’s strengths and weaknesses to make an informed decision.

  • Annual Reports: Access detailed annual reports for a deep dive into the company's long-term vision and management commentary.

Frequently Asked Questions (FAQs)

Q1. What is the current Gujarat Kidney share price?
The real-time share price is displayed at the top of this page. It updates dynamically during market hours to reflect the latest value on the NSE and BSE.

Q2. What does Gujarat Kidney and Super Speciality Ltd. do?
The company operates a chain of multi-speciality hospitals in Gujarat. While they are renowned for kidney care and renal sciences, they also provide comprehensive treatments in general surgery, orthopaedics, internal medicine, and critical care.

Q3. Is Gujarat Kidney and Super Speciality a profitable company?
You can check the latest profitability status by reviewing the "Profit & Loss" and "Quarterly Results" sections on this page. These tables provide the most recent net profit figures declared by the company.

Q4. Does Gujarat Kidney pay dividends?
Dividend declarations depend on the company's profits and management policy. You can check the "Corporate Actions" or "Dividend Yield" section on this page to see if any recent dividends have been announced.

Q5. Where is Gujarat Kidney and Super Speciality listed?
The company is listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) in India.

Q6. How can I download the Gujarat Kidney annual report?
You can find and download the latest annual reports and investor presentations directly from the "Reports" section of this page.

Q7. What is the face value of Gujarat Kidney shares?
The face value of each equity share is Rs 2. This was determined at the time of the company's IPO and listing.

Read More
X